Search by Drug Name or NDC

    NDC 31722-0203-31 LACOSAMIDE 10 mg/mL Details

    LACOSAMIDE 10 mg/mL

    LACOSAMIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is LACOSAMIDE.

    Product Information

    NDC 31722-0203
    Product ID 31722-203_6708697e-b1a3-4de8-b964-21969afb7834
    Associated GPIs
    GCN Sequence Number 064437
    GCN Sequence Number Description lacosamide VIAL 200MG/20ML INTRAVEN
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14344
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name LACOSAMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name LACOSAMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name LACOSAMIDE
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA216335
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0203-31 (31722020331)

    NDC Package Code 31722-203-31
    Billing NDC 31722020331
    Package 10 VIAL, GLASS in 1 CARTON (31722-203-31) / 20 mL in 1 VIAL, GLASS (31722-203-20)
    Marketing Start Date 2022-09-14
    NDC Exclude Flag N
    Pricing Information N/A